Oldroyd Christopher, Avades Tamar, Martin Graham P, Notley Caitlin, Allison Michael E D
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cambridge Liver Unit, Addenbrooke's Hospital, Hills Rd, Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom.
Hepatology Research Group, University of Plymouth, Plymouth, Devon PL4 8AA, United Kingdom.
Alcohol Alcohol. 2025 May 14;60(4). doi: 10.1093/alcalc/agaf027.
Despite the critical importance of alcohol abstinence for patients with advanced liver disease, rates of returning to alcohol remain high and engagement with relapse prevention interventions is low. This study explores the potential barriers to relapse prevention in these patients.
Semi-structured interviews were conducted with patients who had alcohol-related cirrhosis or alcohol-associated hepatitis. Interviews took place during a hospital admission. The study methodology was informed by a constructivist grounded theory approach.
Thirty-three participants were recruited from two sites. Participants had a mean age of 52 (range 30-60) and there were 10 female participants (30%). Most participants were actively drinking alcohol at time of admission (n = 26) and 16 participants were interviewed during their index admission with alcohol-related liver disease.A renewed understanding of the health risk posed by future alcohol made participants confident that they would not return to alcohol use and participants felt that the most important factor in relapse prevention was their own motivation and willpower. However, many rejected the identity label of 'alcoholic' and drew a distinction between themselves and 'bad drinkers'. These factors combined to create a barrier to relapse prevention therapies, since participants felt these were neither appropriate nor necessary for them.
Enhanced self-efficacy, a belief in the importance of willpower, and a rejection of the alcoholic identity can together act to reduce engagement in relapse prevention in patients with advanced liver disease. Relapse prevention interventions should be reframed or redesigned to address these barriers.
尽管戒酒对晚期肝病患者至关重要,但复饮率仍然很高,且参与预防复发干预措施的比例较低。本研究探讨了这些患者预防复发的潜在障碍。
对患有酒精性肝硬化或酒精性肝炎的患者进行了半结构式访谈。访谈在患者住院期间进行。研究方法采用建构主义扎根理论方法。
从两个地点招募了33名参与者。参与者的平均年龄为52岁(范围30 - 60岁),有10名女性参与者(30%)。大多数参与者在入院时仍在积极饮酒(n = 26),16名参与者在其首次因酒精性肝病入院期间接受了访谈。对未来饮酒所带来的健康风险的重新认识使参与者相信他们不会再饮酒,并且参与者认为预防复发的最重要因素是他们自己的动机和意志力。然而,许多人拒绝“酗酒者”这一身份标签,并将自己与“酗酒者”区分开来。这些因素共同构成了预防复发治疗的障碍,因为参与者认为这些治疗对他们既不合适也不必要。
自我效能感增强、对意志力重要性的信念以及对酗酒者身份的拒绝,可能共同导致晚期肝病患者参与预防复发的积极性降低。应重新构建或重新设计预防复发的干预措施以克服这些障碍。